Related Experiment Video
Updated: Jan 22, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Deregulated MTOR (mechanistic target of rapamycin kinase) is responsible for autophagy defects exacerbating kidney
Rei Unno1, Tsuyoshi Kawabata2, Kazumi Taguchi1
1Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.
Abstract:
Kidney stone disease is a lifestyle-related disease prevalent in developed countries; however, effective medical treatment for the disease is not yet well established. As cellular damage in renal tubular cells (RTCs) is responsible for the disease, here, we focused on the role of macroautophagy/autophagy in RTCs. We found that autophagic activity was significantly decreased in mouse RTCs exposed to calcium oxalate (CaOx) monohydrate crystals and in the kidneys of GFP-conjugated MAP1LC3B (microtubule- associated protein 1 light chain 3 beta) transgenic mice with CaOx nephrocalcinosis induced by glyoxylate. This caused accumulation of damaged intracellular organelles, such as mitochondria and lysosomes, the normal functioning of which is mediated by functional autophagy. An impairment of autophagy was also observed in the mucosa with plaques of CaOx kidney stone formers. We determined that the decrease in autophagy was caused by an upregulation of MTOR (mechanistic target of rapamycin kinase), which consequently resulted in the suppression of the upstream autophagy regulator TFEB (transcription factor EB). Furthermore, we showed that an MTOR inhibitor could recover a decrease in autophagy and alleviate crystal-cell interactions and the formation of crystals associated with increased inflammatory responses. Taken together, we conclude that autophagy compromised by MTOR deregulation is a fundamental feature in the pathology of kidney stone formation, and propose that chemical inhibition of MTOR could be a prospective strategy for disease suppression.Abbreviations: ACTB: actin, beta; CaOx: calcium oxalate; CKD: chronic kidney disease; COM: calcium oxalate monohydrate; LGALS3/galectin-3: lectin, galactose binding, soluble 3; GFP: green fluorescent protein; GOX: glyoxylate; HE: hematoxylin and eosin; MAPLC3B: microtubule- associated protein 1 light chain 3 beta; MTOR: mechanistic target of rapamycin kinase; NAC: N-acetyl-L-cysteine; ROS: reactive oxygen species; RTC: renal tubular cell; SQSTM1/p62: sequestosome 1; TFEB: transcription factor EB; TEM: transmission electron microscopy; tfLC3: tandem fluorescent-tagged LC3; 3-MA: 3-methyladenine.
Insights
Kidney stone formation involves decreased autophagy in renal tubular cells due to mTOR activation. Inhibiting mTOR may offer a new treatment strategy for kidney stones by restoring autophagy and reducing inflammation.
Area of Science:
- Nephrology
- Cell Biology
- Molecular Medicine
Background:
- Kidney stone disease is a prevalent lifestyle-related condition with limited effective treatments.
- Cellular damage in renal tubular cells (RTCs) is a key factor in kidney stone development.
- The role of autophagy in RTCs during kidney stone formation requires further investigation.
Purpose of the Study:
- To investigate the role of macroautophagy/autophagy in renal tubular cells during kidney stone formation.
- To identify the molecular mechanisms underlying autophagy impairment in kidney stone disease.
- To explore the therapeutic potential of targeting autophagy for kidney stone treatment.
Main Methods:
- Assessed autophagic activity in mouse RTCs exposed to calcium oxalate (CaOx) crystals and in transgenic mice with induced nephrocalcinosis.
- Examined autophagy in kidney stone patient samples.
- Utilized mechanistic target of rapamycin kinase (MTOR) inhibitors to modulate autophagy.
- Measured crystal-cell interactions and inflammatory responses.
Main Results:
- Autophagic activity was significantly decreased in mouse RTCs and kidneys with CaOx crystals, and in kidney stone formers.
- Impaired autophagy led to the accumulation of damaged organelles, indicating compromised cellular function.
- Decreased autophagy was linked to MTOR upregulation and subsequent suppression of transcription factor EB (TFEB).
- MTOR inhibition restored autophagy, reduced crystal-cell interactions, and alleviated inflammation.
Conclusions:
- Compromised autophagy, driven by MTOR deregulation, is a critical factor in kidney stone pathology.
- MTOR inhibition presents a promising therapeutic strategy for suppressing kidney stone formation.
- Restoring autophagy via MTOR inhibition could mitigate crystal-cell interactions and associated inflammation.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Types of Building Stone
Igneous rocks are formed from the solidification of magma or lava. An example is granite, known for its durability and resistance to weathering, making it ideal for parts of...
Quarrying of Stone
One common method involves using a diamond belt saw to cut large blocks from the quarry face. These blocks can be about 50 feet long and 12 feet high. After the initial vertical cut, drilling is performed at the base of the...
Stone Masonry
Kidney Structure
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

